These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 36462644)

  • 1. Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook.
    Singh N; Shi S; Goel S
    Adv Drug Deliv Rev; 2023 Jan; 192():114638. PubMed ID: 36462644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
    Zarschler K; Rocks L; Licciardello N; Boselli L; Polo E; Garcia KP; De Cola L; Stephan H; Dawson KA
    Nanomedicine; 2016 Aug; 12(6):1663-701. PubMed ID: 27013135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications.
    Jain P; Hassan N; Iqbal Z; Dilnawaz F
    Recent Pat Drug Deliv Formul; 2018; 12(4):228-237. PubMed ID: 30501606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasmall-in-Nano Approach: Enabling the Translation of Metal Nanomaterials to Clinics.
    Cassano D; Pocoví-Martínez S; Voliani V
    Bioconjug Chem; 2018 Jan; 29(1):4-16. PubMed ID: 29186662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-responsive degradable silica nanoparticles: design principles and precision theranostic applications.
    Zhang J; Tang K; Liu Z; Zhang Z; Duan S; Wang H; Yang H; Yang D; Fan W
    Nanoscale Horiz; 2024 Jan; 9(2):186-214. PubMed ID: 38164973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Going even smaller: Engineering sub-5 nm nanoparticles for improved delivery, biocompatibility, and functionality.
    Xie M; Xu Y; Huang J; Li Y; Wang L; Yang L; Mao H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1644. PubMed ID: 32432393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine.
    Montalti M; Prodi L; Rampazzo E; Zaccheroni N
    Chem Soc Rev; 2014 Jun; 43(12):4243-68. PubMed ID: 24643354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
    Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
    Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
    Croissant JG; Fatieiev Y; Almalik A; Khashab NM
    Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles: functionalization and multifunctional applications in biomedical sciences.
    Subbiah R; Veerapandian M; Yun KS
    Curr Med Chem; 2010; 17(36):4559-77. PubMed ID: 21062250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.